Country: United Kingdom
Language: English
Source: HMA (Heads of Medicines Agencies)
florfenicol 300 mg/ml
KELA ALBORATORIES N.V.
QJ01BA90
Solution for injection
florfenicol
Cattle, Pigs
2011-10-26
Issued: February 2012 AN: 00791/2010 Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT NL, CZ, FR, DE, IE, IT, PL, BE, BG, CY, GR, HU, LU, PT, RO, SK: FLORFENIKEL 300 mg/ml solution for injection for pigs ES, DK: KELAFLOR 300 mg/ml solution for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains ACTIVE SUBSTANCE: Florfenicol 300 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for Injection. Clear, light yellow to yellow solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Diseases caused by florfenicol susceptible bacteria. Pigs: Treatment of acute outbreaks of swine respiratory disease caused by strains of _Actinobacillus pleuropneumoniae_ and _Pasteurella multocida_ susceptible to florfenicol. 4.3 CONTRAINDICATIONS Do not use in boars intended for breeding purposes. Do not use in piglets of less than 2 kg. Do not administer to animals with known hypersensitivity to florfenicol or to any of the excipients. Do not administer intravenously._ _ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE (i) Special precautions for use in animals The product should be used in conjunction with susceptibility testing and take into account official and local antimicrobial policies. Issued: February 2012 AN: 00791/2010 Page 2 of 4 The stopper must be cleaned before removing each dose. Use a dry, sterile syringe and nee Read the complete document